The mission of the WMIS is to act as a nexus for all aspects of molecular imaging by providing a cornerstone for state-of-the-art-science and by acting as a driving force behind the development of new scientific principles and programs. An equally important and complementary aim of the WMIS is facilitating the global dissemination of research at the cutting edge of the development and deployment of new tools and technologies, and we will continue to work with our international colleagues to ensure that our voice reflects advances taking place around the world. As a direct result, the WMIS annual meeting and its international flavor has often been the platform where we have learned about the latest and greatest advances in molecular imaging-from software and hardware development to novel probe design and first-in-human trials. The meeting in Hawaii will be no exception. Professor H. Charles Manning, this year's Program Chair, has built a program full of innovative ideas, advanced education concepts, and paradigm-shifting science.
One of the main focuses of the Hawaii meeting will be highlighting our new collaborative initiative with the National Cancer Institute on the topic of Best Practices for Co-clinical Trials. To this end, the WMIS, working closely with the American Association of Physicists in Medicine (AAPM), will explore how to promote best practices in quantitative molecular imaging for the best outcomes in coclinical trials. The WMIS and AAPM are remarkably wellsuited partners for this initiative, as the WMIS will focus primarily on preclinical imaging, while the AAPM will be principally concerned with physical standards for co-clinical trials. This is truly an exciting and forward-thinking initiative and, in keeping with our theme, falls very much in line with the concept of precision medicine.
In 2014, we initiated some significant changes to the operations of the WMIC. In partnership with ESMI and FASMI and with the overwhelming support of our membership and industry partners, the WMIS is announcing a new rotation strategy for future WMICs. In an attempt to create greater access to the conference, the Congress will now be held predominately in the USA. Therefore, WMIC 2016 will now be held in New York City! We will continue to work with our international colleagues to ensure that our voice reflects the advances taking place around the world, and this announcement has already created excitement with our North American, European, and Asian members.
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The journal Molecular Imaging and Biology (MIB), edited by Ray Gibson, now has a turnaround time on an average of 41 days (from submission to final decision) with an acceptance rate in 2014 of 45 %. As a truly international journal that publishes work from our WMIS, FASMI, and ESMI members, we have now named Regional Associate Editors from the USA (Dr. Anna Moore), Europe (Dr. Bertrand Tavitian), and Asia (Dr. Mei Tian) who will work closely with Ray to ensure that only the best science is published in MIB and will help in developing strategies for our global effort in building up MIB as the leading journal in molecular imaging.
In closing, I want to say that it has been my pleasure and honor to be the President of the WMIS this last year, a term that will culminate in the Hawaii meeting. Needless to say, I very strongly believe in the mission of the WMIS. Your participation in and support of the WMIS is vital for its success. Professor Christopher Contag of Stanford University will be our next President, and I am certain he will do an exceptional job in guiding the society to its next level. In the end, the WMIC is driven by its membership. Be active! Get involved! This is your society, and you can help steer its direction. Thank you for your support this year, Aloha!
